Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

KS Biomedix


KS Biomedix is planning to acquire Avicenna Medica of Canada for £42m, partly funded by a £16m share placing.
20-Jun-2001


KS Biomedix is raising £15m in a share issue in order to fund the development of new treatments for rheumatoid arthritis and osteoarthritis.
29-Feb-2000